Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 50 tablets per bottle. [Brand, NDC] NDC DG Health: 55910-852-71; NDC Good Neighbor Pharmacy: 46122-224-71; NDC Good Sense: 0113-0852-71; NDC Harris Teeter: 69256-041-71; NDC Kroger: 30142-600-71; NDC Major: 0904-6716-51; NDC Meijer: 41250-852-71; NDC Publix: 56062-099-71; NDC Rite Aid: 11822-0852-2; NDC Signature Care: 21130-116-71; NDC Topcare: 36800-852-71
Published March 25, 2020 · Recall initiated: October 23, 2019
Summary
FDA records drug Class II recall D-1021-2020, published March 25, 2020 and initiated October 23, 2019. Recalling firm: Perrigo Company PLC; Status: Terminated; Lot: Lots: 8AE1744, 8BE1369, 8CE1377, 8CE1378, 8DE1103, 8DE1531, 8EE1700, 8FV0829, 8DE1722, 8EE1317, 8FE1635, 8GE1921, 8HE1342, 8KE2503R, 8JE2154, 8KE2503, 8LE2198, 8LE2597, 9AE2499, 9BE2862, 9BE2863, 9CE3723, 9DE2890, 9DE2891, 9EE2812, 9FE3187, 9GE2885, 9HE3435, 9JE2656. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Perrigo Company PLC
- Distributor
- Nationwide USA
- Lot
- Lots: 8AE1744, 8BE1369, 8CE1377, 8CE1378, 8DE1103, 8DE1531, 8EE1700, 8FV0829, 8DE1722, 8EE1317, 8FE1635, 8GE1921, 8HE1342, 8KE2503R, 8JE2154, 8KE2503, 8LE2198, 8LE2597, 9AE2499, 9BE2862, 9BE2863, 9CE3723, 9DE2890, 9DE2891, 9EE2812, 9FE3187, 9GE2885, 9HE3435, 9JE2656
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASevere Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,March 2, 2022
- FDAAcetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle,March 2, 2022
- FDANo Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, Distributed byMarch 2, 2022
- FDASevere Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,March 2, 2022
- FDAMaximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 40 tablets per bottle. [Brand, NDC]March 25, 2020
- FDAMaximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 65 tablets per bottle. [Brand, NDC] NDC CareMarch 25, 2020
Questions about this recall
Was Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 50 tablets per bottle. [Brand, NDC] NDC DG Health: 55910-852-71; NDC Good Neighbor Pharmacy: 46122-224-71; NDC Good Sense: 0113-0852-71; NDC Harris Teeter: 69256-041-71; NDC Kroger: 30142-600-71; NDC Major: 0904-6716-51; NDC Meijer: 41250-852-71; NDC Publix: 56062-099-71; NDC Rite Aid: 11822-0852-2; NDC Signature Care: 21130-116-71; NDC Topcare: 36800-852-71 recalled?
Yes. FDA published recall D-1021-2020 on March 25, 2020. Reported hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release